Mednax said on Dec. 11 that Starboard Value has submitted nominations for a majority slate of directors at the company’s 2020 shareholders meeting.
The firm owns medical practices and provides services such as anesthesia and neonatal care. Mednax said it is aware the activist fund had taken a stake and that it had met with Starboard.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Ryanair says Europe delays may mean no MAX jets next summerRyanair may not receive any 737 Max aircraft from Boeing by next summer over Eur...
Source: Reuters - 🏆 2. / 97 Read more »
Did Cara Delevingne Just Tweet About Breaking Up with Ashley Benson?A cryptic tweet may not be what it seems.
Source: harpersbazaarus - 🏆 467. / 52 Read more »
Labor unions win, drug companies lose in new trade dealThe big winners and losers from the Trump administration’s deal with Democrats on its NAFTA replacement, the U.S.-Mexico-Canada Agreement, are not necessarily the traditional ones Pharmaceutical companies, which usually see gains from trade deals, got their big promise ripped out of the final agreement. But it gives labor groups the first trade deal it could support in nearly two decades because of strong enforcement of labor rules
Source: politico - 🏆 381. / 59 Read more »
Man found guilty of murder in gruesome killings of engaged doctors in their Boston penthouseA jury on Tuesday found Bampumim Teixeira guilty of first-degree felony murder in the slayings of two doctors found lying in pools of blood in their Boston penthouse in May 2017. Is he the fall guy Coach Park Hang seo Magic is becoming an organized and well-rounded soccer powerhouse that has the confidence to beat even the Spanish and Brazilian teams. D-block
Source: cnnbrk - 🏆 393. / 55 Read more »
Sanofi growth cure comes with M&A health warningThe 108 bln euro drugmaker is cutting costs, exiting areas like diabetes, and hinting it might sell assets. It’s a bold but logical move to boost the group’s flagging sales. New CEO Paul Hudson’s main other task is to show he can shake off Sanofi’s mixed dealmaking track record.
Source: Breakingviews - 🏆 470. / 51 Read more »